Kelly McKee

Kelly McKee

Chief Tech/Sci/R&D Officer at GEOVAX LABS, INC.

Net worth: 96 $ as of 31/07/2026

76 year
Commercial Services
Consumer Services
Technology Services

Profile

Kelly T.
McKee
is Chief Medical Officer at GeoVax Labs, Inc. since 2022.
Former positions include Operations Director at Quintiles Transnational Corp., Senior Director-Clinical Research at DynPort Vaccine Co. LLC, Vice President-Vaccines & Public Health at IQVIA, Inc., Chief Medical Officer at Pharm-Olam International Ltd., and Chief Medical Officer at Bravovax Co., Ltd. Education includes undergraduate studies at Davidson College, graduate studies at The Johns Hopkins University, and a doctorate from The University of Virginia School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
17/06/2026 141 ( 0% ) 96 $ 31/07/2026

Kelly McKee active positions

CompaniesPositionStart
GEOVAX LABS, INC. Chief Tech/Sci/R&D Officer 06/01/2022

Former positions of Kelly McKee

CompaniesPositionEnd
IMS HEALTH, INC. Corporate Officer/Principal -
Bravovax Co., Ltd.
Chief Tech/Sci/R&D Officer -
Corporate Officer/Principal -
Chief Tech/Sci/R&D Officer -
Chief Operating Officer -
See the detail of Kelly McKee's experience

Training of Kelly McKee

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

18

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Commercial Services

Technology Services

Commercial Services

Consumer Services

Consumer Services

Health Technology

Commercial Services

Consumer Services

Bravovax Co., Ltd.